The insulin patch pumps market size has grown rapidly in recent years. It will grow from $1.56 billion in 2025 to $1.73 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increasing prevalence of diabetes worldwide, rising demand for intensive insulin therapy, expansion of insulin pump adoption, improvements in wearable medical device technology, growing patient awareness of advanced diabetes management.
The insulin patch pumps market size is expected to see rapid growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing adoption of closed-loop insulin delivery systems, rising investments in digital diabetes care, expansion of personalized insulin therapy solutions, increasing demand for remote glucose monitoring, advancements in miniaturized pump technologies. Major trends in the forecast period include increasing adoption of tubeless patch pump systems, rising demand for connected and smart insulin pumps, growing integration of continuous glucose monitoring, expansion of automated insulin delivery technologies, enhanced focus on discreet and wearable designs.
The increasing prevalence of diabetes worldwide is expected to drive the growth of the insulin patch pumps market during the forecast period. Diabetes is a major global health concern, often influenced by lifestyle and dietary habits. Insulin patch pumps facilitate the convenient delivery of insulin directly into the body, and many people with diabetes find them more practical than traditional insulin injections. The rising number of diabetes cases is therefore creating a growing demand for insulin patch pumps. For example, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%. Additionally, the proportion of patients achieving target HbA1c levels reached 37.9%, the highest value ever reported by the National Diabetes Audit (NDA). Consequently, the global increase in diabetes prevalence is expected to propel the insulin patch pumps market.
Companies in the insulin patch pumps market are focusing on product innovation, such as advanced infusion sets, to provide reliable and convenient insulin delivery solutions. Infusion sets for insulin pumps are designed for continuous subcutaneous insulin infusion, typically worn for up to seven days. For instance, in September 2024, Embecta, a U.S.-based diabetes care company, received FDA 510(k) clearance for its first insulin patch pump, featuring a 300-unit insulin reservoir and designed for up to three days of wear. This launch represents a significant advancement in insulin delivery, offering patients a flexible and convenient option while reducing device burden.
In January 2023, Tandem Diabetes Care Inc., a US-based medical device manufacturer, acquired AMF Medical SA for an undisclosed amount. This acquisition allows Tandem Diabetes Care to expand its diabetes care portfolio and extend the benefits of advanced insulin pump therapy to more patients. AMF Medical SA is a Switzerland-based MedTech company specializing in the development of insulin patch pumps.
Major companies operating in the insulin patch pumps market are Insulet Corporation, Medtronic PLC, Tandem Diabetes Care Inc., Ypsomed Holding AG, AMF Medical SA, Cequr SA, Debiotech SA, Bigfoot Biomedical Inc., Valeritas Inc., Cellnovo Group SA, Medella Health Ltd., ViCentra B.V., SFC Fluidics Inc., Pancreum Inc., Beta Bionics Inc., Embecta Corp., SOOIL Development Co. Ltd., EOFLOW Co. Ltd., 3S Corporation, Apex Medical Devices.
North America was the largest region in the insulin patch pumps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin patch pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the insulin patch pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the insulin patch pumps market by increasing costs of imported sensors, micro-pumps, electronic controllers, batteries, and medical-grade plastics. Healthcare providers and device manufacturers in North America and Europe are most affected due to reliance on imported components, while Asia-Pacific faces higher production costs for exports. These tariffs are raising device prices and slowing adoption rates. However, they are also supporting local manufacturing, regional electronics sourcing, and innovation in cost-efficient wearable insulin delivery solutions.
The insulin patch pumps market research report is one of a series of new reports that provides insulin patch pumps market statistics, including insulin patch pumps industry global market size, regional shares, competitors with a insulin patch pumps market share, detailed insulin patch pumps market segments, market trends and opportunities, and any further data you may need to thrive in the insulin patch pumps industry. This insulin patch pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Insulin patch pumps, compact computerized devices with pre-programmed insulin dosage delivery, offer diabetic patients a convenient means of managing their blood sugar levels. Typically attached to a strap beneath clothing, in a pocket, on a waist belt, or affixed with an adhesive patch on the patient's stomach or arm, these devices facilitate discreet and accessible insulin administration.
The primary categories of insulin patch pumps include traditional insulin pumps, smart insulin pumps, and disposable insulin pumps. Traditional insulin pumps are small devices that deliver insulin through a plastic tube, providing a continuous supply throughout the day and night. Additionally, before meals, they can administer insulin more rapidly, employing the basal and bolus delivery modes. These pumps are available in two types: tethered pumps and patch pumps, catering to patients with both type 1 and type 2 diabetes. Widely utilized in hospitals, clinics, laboratories, and other medical settings, these insulin patch pumps play a pivotal role in diabetes management.
The insulin patch pumps market consist of sales of insulin reservoir, pumping, mechanism and cannula. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The insulin patch pumps market size is expected to see rapid growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing adoption of closed-loop insulin delivery systems, rising investments in digital diabetes care, expansion of personalized insulin therapy solutions, increasing demand for remote glucose monitoring, advancements in miniaturized pump technologies. Major trends in the forecast period include increasing adoption of tubeless patch pump systems, rising demand for connected and smart insulin pumps, growing integration of continuous glucose monitoring, expansion of automated insulin delivery technologies, enhanced focus on discreet and wearable designs.
The increasing prevalence of diabetes worldwide is expected to drive the growth of the insulin patch pumps market during the forecast period. Diabetes is a major global health concern, often influenced by lifestyle and dietary habits. Insulin patch pumps facilitate the convenient delivery of insulin directly into the body, and many people with diabetes find them more practical than traditional insulin injections. The rising number of diabetes cases is therefore creating a growing demand for insulin patch pumps. For example, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%. Additionally, the proportion of patients achieving target HbA1c levels reached 37.9%, the highest value ever reported by the National Diabetes Audit (NDA). Consequently, the global increase in diabetes prevalence is expected to propel the insulin patch pumps market.
Companies in the insulin patch pumps market are focusing on product innovation, such as advanced infusion sets, to provide reliable and convenient insulin delivery solutions. Infusion sets for insulin pumps are designed for continuous subcutaneous insulin infusion, typically worn for up to seven days. For instance, in September 2024, Embecta, a U.S.-based diabetes care company, received FDA 510(k) clearance for its first insulin patch pump, featuring a 300-unit insulin reservoir and designed for up to three days of wear. This launch represents a significant advancement in insulin delivery, offering patients a flexible and convenient option while reducing device burden.
In January 2023, Tandem Diabetes Care Inc., a US-based medical device manufacturer, acquired AMF Medical SA for an undisclosed amount. This acquisition allows Tandem Diabetes Care to expand its diabetes care portfolio and extend the benefits of advanced insulin pump therapy to more patients. AMF Medical SA is a Switzerland-based MedTech company specializing in the development of insulin patch pumps.
Major companies operating in the insulin patch pumps market are Insulet Corporation, Medtronic PLC, Tandem Diabetes Care Inc., Ypsomed Holding AG, AMF Medical SA, Cequr SA, Debiotech SA, Bigfoot Biomedical Inc., Valeritas Inc., Cellnovo Group SA, Medella Health Ltd., ViCentra B.V., SFC Fluidics Inc., Pancreum Inc., Beta Bionics Inc., Embecta Corp., SOOIL Development Co. Ltd., EOFLOW Co. Ltd., 3S Corporation, Apex Medical Devices.
North America was the largest region in the insulin patch pumps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin patch pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the insulin patch pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the insulin patch pumps market by increasing costs of imported sensors, micro-pumps, electronic controllers, batteries, and medical-grade plastics. Healthcare providers and device manufacturers in North America and Europe are most affected due to reliance on imported components, while Asia-Pacific faces higher production costs for exports. These tariffs are raising device prices and slowing adoption rates. However, they are also supporting local manufacturing, regional electronics sourcing, and innovation in cost-efficient wearable insulin delivery solutions.
The insulin patch pumps market research report is one of a series of new reports that provides insulin patch pumps market statistics, including insulin patch pumps industry global market size, regional shares, competitors with a insulin patch pumps market share, detailed insulin patch pumps market segments, market trends and opportunities, and any further data you may need to thrive in the insulin patch pumps industry. This insulin patch pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Insulin patch pumps, compact computerized devices with pre-programmed insulin dosage delivery, offer diabetic patients a convenient means of managing their blood sugar levels. Typically attached to a strap beneath clothing, in a pocket, on a waist belt, or affixed with an adhesive patch on the patient's stomach or arm, these devices facilitate discreet and accessible insulin administration.
The primary categories of insulin patch pumps include traditional insulin pumps, smart insulin pumps, and disposable insulin pumps. Traditional insulin pumps are small devices that deliver insulin through a plastic tube, providing a continuous supply throughout the day and night. Additionally, before meals, they can administer insulin more rapidly, employing the basal and bolus delivery modes. These pumps are available in two types: tethered pumps and patch pumps, catering to patients with both type 1 and type 2 diabetes. Widely utilized in hospitals, clinics, laboratories, and other medical settings, these insulin patch pumps play a pivotal role in diabetes management.
The insulin patch pumps market consist of sales of insulin reservoir, pumping, mechanism and cannula. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Insulin Patch Pumps Market Characteristics
3. Insulin Patch Pumps Market Supply Chain Analysis
4. Global Insulin Patch Pumps Market Trends and Strategies
5. Insulin Patch Pumps Market Analysis of End Use Industries
7. Global Insulin Patch Pumps Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Insulin Patch Pumps Total Addressable Market (TAM) Analysis for the Market
9. Insulin Patch Pumps Market Segmentation
10. Insulin Patch Pumps Market Regional and Country Analysis
11. Asia-Pacific Insulin Patch Pumps Market
12. China Insulin Patch Pumps Market
13. India Insulin Patch Pumps Market
14. Japan Insulin Patch Pumps Market
15. Australia Insulin Patch Pumps Market
16. Indonesia Insulin Patch Pumps Market
17. South Korea Insulin Patch Pumps Market
18. Taiwan Insulin Patch Pumps Market
19. South East Asia Insulin Patch Pumps Market
20. Western Europe Insulin Patch Pumps Market
21. UK Insulin Patch Pumps Market
22. Germany Insulin Patch Pumps Market
23. France Insulin Patch Pumps Market
24. Italy Insulin Patch Pumps Market
25. Spain Insulin Patch Pumps Market
26. Eastern Europe Insulin Patch Pumps Market
27. Russia Insulin Patch Pumps Market
28. North America Insulin Patch Pumps Market
29. USA Insulin Patch Pumps Market
30. Canada Insulin Patch Pumps Market
31. South America Insulin Patch Pumps Market
32. Brazil Insulin Patch Pumps Market
33. Middle East Insulin Patch Pumps Market
34. Africa Insulin Patch Pumps Market
36. Insulin Patch Pumps Market Competitive Landscape and Company Profiles
37. Insulin Patch Pumps Market Other Major and Innovative Companies
40. Insulin Patch Pumps Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Insulin Patch Pumps Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses insulin patch pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for insulin patch pumps? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The insulin patch pumps market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Reusable Insulin Patch Pumps; Fully Disposable Insulin Patch Pumps; Smart Or Connected Insulin Patch Pumps; Automated Insulin Patch Pumps2) By Mode: Basal; Bolus
3) By Application: Type 1 Diabetes; Type 2 Diabetes
Subsegments:
1) By Reusable Insulin Patch Pumps: Reusable Controller with Disposable Patch Modules; Reusable Controller with Replaceable Insulin Reservoirs; Hybrid Reusable Patch Pump Systems2) By Fully Disposable Insulin Patch Pumps: Pre-Filled Disposable Insulin Patch Pumps; Refillable Disposable Insulin Patch Pumps; Short-Wear Disposable Patch Pumps (24-72 hours)
3) By Smart or Connected Insulin Patch Pumps: Bluetooth-Enabled Insulin Patch Pumps; Mobile App-Integrated Patch Pumps; Cloud-Connected Insulin Patch Pumps
4) By Automated Insulin Patch Pumps: Hybrid Closed-Loop Insulin Patch Pumps; Fully Closed-Loop (Autonomous) Insulin Patch Pumps; CGM-Integrated Automated Patch Pumps
Companies Mentioned: Insulet Corporation; Medtronic PLC; Tandem Diabetes Care Inc.; Ypsomed Holding AG; AMF Medical SA; Cequr SA; Debiotech SA; Bigfoot Biomedical Inc.; Valeritas Inc.; Cellnovo Group SA; Medella Health Ltd.; ViCentra B.V.; SFC Fluidics Inc.; Pancreum Inc.; Beta Bionics Inc.; Embecta Corp.; SOOIL Development Co. Ltd.; EOFLOW Co. Ltd.; 3S Corporation; Apex Medical Devices
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Insulin Patch Pumps market report include:- Insulet Corporation
- Medtronic PLC
- Tandem Diabetes Care Inc.
- Ypsomed Holding AG
- AMF Medical SA
- Cequr SA
- Debiotech SA
- Bigfoot Biomedical Inc.
- Valeritas Inc.
- Cellnovo Group SA
- Medella Health Ltd.
- ViCentra B.V.
- SFC Fluidics Inc.
- Pancreum Inc.
- Beta Bionics Inc.
- Embecta Corp.
- SOOIL Development Co. Ltd.
- EOFLOW Co. Ltd.
- 3S Corporation
- Apex Medical Devices
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.73 Billion |
| Forecasted Market Value ( USD | $ 2.55 Billion |
| Compound Annual Growth Rate | 10.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
